Hematologic Oncology Update
Dr. Neil Love
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Episodes
Mentioned books
Jun 2, 2025 • 48min
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. CME information and select publications here.
May 31, 2025 • 51min
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
In this engaging discussion, Dr. Natalie Callender and Dr. Tom Martin, renowned experts in hematologic oncology, tackle the intricacies of multiple myeloma treatment. They delve into unique challenges for elderly patients, highlighting key findings from the AQUILA trial that enhance treatment strategies. The episode also explores the promising role of Selenexer and advances in CAR T-cell therapies, bringing light to the complexities of neurotoxicity and emerging therapies. The conversation emphasizes personalized treatment approaches for better outcomes in diverse patient demographics.
May 29, 2025 • 51min
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.
May 25, 2025 • 48min
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. CME information and select publications here.
May 23, 2025 • 43min
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME information and select publications here.
May 20, 2025 • 50min
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas. CME information and select publications here.
May 16, 2025 • 37min
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME information and select publications here.
May 12, 2025 • 50min
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma. CME information and select publications here.
May 10, 2025 • 53min
Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Dr John P Leonard from Weill Cornell Medicine in New York, New York, reviews data presented at the 2024 ASH Annual Meeting and their implications for the treatment of non-Hodgkin lymphomas. CME information and select publications here.
May 3, 2025 • 59min
Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
Dr. Jennifer R Brown, a leader in CLL research at Dana-Farber, and Prof. Paolo Ghia from Milan, dive into the latest breakthroughs in chronic lymphocytic leukemia. They explore the role of new therapies like BTK inhibitors, comparing their effectiveness with traditional treatments. The conversation highlights the significance of monitoring minimal residual disease and discusses recent findings on treatment risks like hypertension. They also touch on innovative strategies emerged during the COVID-19 pandemic, paving the way for future advancements in CLL care.
